ML
MLSS.US Milestone Scientific
- Market cap
- USD 26.6M
- P/E
- -
- P/B
- 8.01x
- ROE
- -96.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MLSS.US undervalued?
Graham numberThe Graham number of Milestone Scientific cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Milestone Scientific fundamental analysis
No fundamental analysis for Milestone Scientific yet.
Milestone Scientific stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System …
Full company profileMilestone Scientific financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Milestone Scientific annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 10.5M | 11.3M | 9.62M | 8.37M | 5.44M | 10.3M | 8.81M | 9.83M | 8.63M | 8.97M | 9.63M |
| Gross Profit | 6.31M | 6.97M | 4.43M | 5.72M | 3.62M | 6.31M | 4.90M | 6.79M | 6.43M | 6.33M | 6.75M |
| Operating Income | -6.51M | -5.23M | -8.00M | -4.00M | -7.45M | -7.38M | -8.83M | -7.11M | -6.76M | -5.70M | -3.51M |
| EBITDA | -6.35M | -4.66M | -5.58M | -7.39M | -7.36M | -6.79M | -8.63M | -6.83M | -4.58M | -5.51M | -3.36M |
| Net Income | -5.95M | -5.19M | -7.43M | -7.52M | -7.34M | -6.82M | -8.71M | -6.93M | -4.71M | -5.72M | -3.53M |
| EPS | -0.22 | -0.16 | -0.21 | -0.16 | -0.12 | -0.10 | -0.12 | -0.10 | -0.06 | -0.07 | -0.04 |
| Balance Sheet | |||||||||||
| Total Assets | 13.6M | 15.6M | 6.40M | 6.56M | 19.6M | 19.8M | 13.7M | 11.4M | 9.80M | 7.81M | 6.94M |
| Total Liabilities | 5.01M | 8.13M | 4.87M | 4.93M | 3.46M | 3.59M | 3.70M | 3.36M | 3.96M | 4.99M | 3.29M |
| Shareholders' Equity | 8.50M | 7.24M | 1.54M | 1.70M | 16.2M | 16.4M | 10.2M | 8.01M | 5.83M | 2.81M | 3.66M |
| Cash & Short-term Investments | 3.60M | 2.64M | 743K | 1.52M | 14.2M | 14.8M | 8.72M | 5.95M | 3.26M | 1.11M | 1.32M |
| Total Debt | - | - | - | 16.0K | 943K | 587K | 497K | 396K | 349K | 1.02M | 113K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -5.40M | -1.23M | -1.63M | -1.78M | -6.98M | -4.02M | -6.03M | -5.33M | -2.92M | -2.92M | -1.66M |
| Capital Expenditure | 31.0K | 199K | 7.40K | 9.92K | 21.4K | 15.2K | 8.53K | 4.88K | 10.1K | 15.1K | 9.91K |
| Free Cash Flow | -5.43M | -1.43M | -1.64M | -1.79M | -7.01M | -4.03M | -6.04M | -5.33M | -2.93M | -2.93M | -1.67M |
| Ratios | |||||||||||
| ROE | -70.0% | -71.6% | -482.7% | -443.7% | -45.3% | -41.7% | -85.1% | -86.5% | -80.8% | -203.4% | -96.5% |
| ROA | -43.9% | -33.2% | -116.1% | -114.8% | -37.5% | -34.4% | -63.5% | -60.9% | -48.1% | -73.3% | -50.8% |
| Net Profit Margin | -56.7% | -46.0% | -77.2% | -89.8% | -134.9% | -66.2% | -98.9% | -70.5% | -54.6% | -63.8% | -36.6% |
| Debt to Equity | - | - | - | 0.01x | 0.06x | 0.04x | 0.05x | 0.05x | 0.06x | 0.36x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Milestone Scientific dividends
Milestone Scientific has not paid dividends in the last 9 fiscal years.
Last stock split: 1:3 on Jan 14, 2004.
Who owns Milestone Scientific
- Insiders 16.02%
- Institutions 5.58%
- Public & others 78.40%
- Shares outstanding 90.6M
- Free float 74.5M
Milestone Scientific company profile
- Company name
- Milestone Scientific
- Ticker
- MLSS.US
- Exchange
- USA Stocks
- Listed since
- Nov 3, 1995
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15
- Fiscal year end
- December
- Address
- 425 Eagle Rock Avenue, Roseland, NJ, United States, 07068
- Phone
- 973 535 2717
- Website
- milestonescientific.com
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Milestone Scientific management
5- Ms. Benedetta I. CasamentoExecutive Chairman · born 1967
- Mr. Eric C. HinesCEO, President & Director · born 1968
- Mr. Leonard A. OsserFounder · born 1947
- Ms. Keisha Harcum M.B.A., M.S.Vice President of Finance
- Mr. Jason PapesSenior VP and Global Head of Sales & Marketing